Contact information
RESEARCH GROUPS
Oxford Haemophilia & Thrombosis Centre; NIHR Oxford Biomedical Research Centre
University of Aberdeen; Thrombosis & Haemostasis laboratory
https://www.abdn.ac.uk/people/gael.morrow1
Gael Morrow
Post-doctoral researcher
My main research interest lies in fibrinolysis (degradation of a blood clot) and how the clot structure alters the rate of lysis. I am currently working with Dr Nicola Curry and her team of clinicians at the Oxford Haemophilia and Thrombosis Centre at the Churchill Hospital.
My work focuses on two different types of fibrinogen replacement administered to trauma patients. Fibrinogen is the key pro-coagulant factor required for stable clot formation. Patients recruited to the Fibrinogen Early in Severe Trauma StudY (FEISTY) were given one of two treatments: cryoprecipitate or fibrinogen concentrate. My research investigates the differences in clot structure and strength between the two fibrinogens, and how this correlates with clinical outcome.
Recent publications
-
Journal article
MORROW G. et al, (2021), Frontiers in Cardiovascular Medicine
-
Journal article
Morrow GB. et al, (2021), Int J Mol Sci, 22
-
Journal article
Morrow GB. et al, (2021), Thromb Res, 197, 100 - 108
-
Journal article
Whyte CS. et al, (2020), Blood
-
Journal article
Morrow GB. et al, (2020), J Thromb Haemost, 18, 1576 - 1585
-
Journal article
Whyte CS. et al, (2020), J Thromb Haemost
-
Journal article
Morrow GB. et al, (2019), Haematologica, haematol.2019.230367 - haematol.2019.230367
-
Coagulation status of critically ill patients with liver disease assessed using a novel thrombin generation analyser
Conference paper
Morrow GB. et al, (2019), BRITISH JOURNAL OF HAEMATOLOGY, 185, 137 - 137
-
Journal article
Morrow GB. et al, (2014), Purinergic Signalling, 10, 581 - 585